Elastin Biosciences
Platform to Tackle Elastin Loss
About Us
Elastin Bioscience Company
Elastin Biosciences, a spin-out from Longaevus Technologies, is pioneering therapeutics that restore the body’s structural foundation.
By addressing extracellular matrix deterioration — a newly recognized hallmark of aging — we target a shared mechanism underlying cardiovascular, pulmonary, and dermal degeneration.
What Is Elastin?
_____
Elastin, is one of the most dominant proteins in the body expressed in the:
Lungs
Skin
Vascular System
The vast majority of elastin is deposited before adolescence, with synthesis essentially halting thereafter.
As We Age
___________
Elastin loss
Elastin degrades over time due to mechanical stress, chronic inflammation, UV damage and a wide variety of diseases.
This not only leads to loss of structural integrity. The by-products of elastin degradation are biochemically active and further drive the aging process.
Our Approach
______________
Elastin Restoration Platform
At Elastin Bioscienes, our team is developing an Elastin Restoration Platform to tackle elastin loss. Our approach develops a continuous pipeline of small molecules using cheminformatics, testing on human cells followed by testing on disease models of Elastin-related diseases.
Pipeline
_______________
Our small molecule assets developed at Elastin Biosciences mark a new era in elastin research. These molecules are designed to not only boost elastin production but also to fortify the structural integrity of crucial tissues, particularly in the cardiovascular system.
In Vivo Success: Our research has yielded promising results beyond theoretical confines, showcasing significant increases in elastin expression and enhanced arterial strength in our in vivo studies.
Grants
A multinational EU-funded programme to develop a first-in-class treatment for Williams Syndrome.
WISER Consortium
Lead Institution: Elastin Biosciences
News
January 25, 2026
Milner Institute - Elastin Biosciences opens central lab at the Milner Institute in Cambridge
February 30, 2026
Milner Institute - Ecosystem Insights: Rihab Gam, Elastin Biosciences
Our Head of Biology gets the spotlight from the Milner Institute
September 30, 2025
University of Pennsylvania - ACE-ICRWS: Dual-Mechanism Therapy Reverses Vascular Aging
Presented at the International Conference on Research in Williams Syndrome, this talk detailed how our ElastoCure platform modulates critical genes to restore aortic health.
August, 1 2024
Lifespan.io - Targeting Williams and Marfan Syndromes
In this featured interview, CEO Sherif Idriss discusses the systemic rejuvenation observed in preclinical models, including improved mobility and vitality.
June 3, 2024
BioSpace - Elastin Biosciences Announces Positive Preclinical In Vivo Data Demonstrating Elastin Preservation and Restoration in Models of Abdominal Aortic Aneurysm and Williams Syndrome
September, 1, 2023
BioSpace - Elastin Biosciences Announces Breakthrough Discovery in Elastin Restoration: Paving the Way for Treatment of Elastin-Deficiency Diseases
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!